(Q41535988)

2 October 2017

1 reference

title

Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation (English)

1 reference

2 October 2017

1 reference

Ryall RL

1

1 reference

2 October 2017

publication date

1 January 1997

1 reference

2 October 2017

published in

World Journal of Urology

1 reference

2 October 2017

volume

15

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

155-164

1 reference

Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02201852

Urinary Tamm-Horsfall glycoprotein in certain kidney diseases and its content in renal and bladder calculi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02201852

Affinity-purified antibodies of defined specificity for use in a solid-phase microplate radioimmunoassay of human Tamm-Horsfall glycoprotein in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02201852

The nature of the non-ultrafilterable glycosaminoglycans of normal human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02201852

Magnesium reduces calcium oxalate crystal formation in human whole urine

21 January 2018

1 reference

12 December 2020

Studies in inhibitors of calcification and levels of urine saturation with calcium salts in recurrent stone patients

1 reference

12 December 2020

Blood coagulation proteins and urolithiasis are linked: crystal matrix protein is the F1 activation peptide of human prothrombin

1 reference

12 December 2020

A study of glycosaminoglycan excretion in normal and stone-forming subjects using a modified cetylpyridinium chloride technique

1 reference

12 December 2020

Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis

1 reference

12 December 2020

Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine

1 reference

12 December 2020

Urinary Citrate Excretion in Stone‐Formers and Normal Controls

1 reference

12 December 2020

The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons

1 reference

12 December 2020

Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization

1 reference

12 December 2020

Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers

1 reference

12 December 2020

Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine

1 reference

12 December 2020

Effects of chondroitin sulphate, human serum albumin and Tamm-Horsfall mucoprotein on calcium oxalate crystallization in undiluted human urine

1 reference

12 December 2020

Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily

1 reference

12 December 2020

THE RENAL CLEARANCE OF CITRATE IN MAN

1 reference

12 December 2020

Raising urinary citrate lowers calcium oxalate and calcium phosphate crystal formation in whole urine

1 reference

12 December 2020

The effect of two new semi-synthetic glycosaminoglycans (G871, G872) on the zeta potential of calcium oxalate crystals and on growth and agglomeration

1 reference

12 December 2020

The effect of heparan sulphate on the crystallization of calcium oxalate in undiluted, ultrafiltered human urine

1 reference

12 December 2020

Effects of magnesium on calcium oxalate crystallization

1 reference

12 December 2020

Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic

1 reference

12 December 2020

A quantitative investigation of the effects on the growth of calcium oxalate crystals on potential inhibitors.

1 reference

12 December 2020

Pyrophosphate does not influence calcium oxalate or calcium phosphate crystal formation in concentrated whole human urine

1 reference

12 December 2020

Possible role for chondroitin sulfate in urolithiasis: in vivo studies in an experimental model

1 reference

12 December 2020

Citrate and renal calculi

1 reference

12 December 2020

Role of inhibitor deficiency in urolithiasis. I. Rationale of urinary magnesium, citrate, pyrophosphate and glycosaminoglycan determinations.

1 reference

12 December 2020

Activity products in stone-forming and non-stone-forming urine

1 reference

12 December 2020

Tamm-Horsfall mucoproteins promote calcium oxalate crystal formation in urine: quantitative studies

1 reference

12 December 2020

Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization

1 reference

12 December 2020

Preliminary results of glycosminoglycans excretion in normal and stone forming subjects: relationship with uric acid excretion

1 reference

12 December 2020

Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects

1 reference

12 December 2020

A method for studying inhibitory activity in whole urine

1 reference

12 December 2020

Citrate and renal calculi: an update.

1 reference

12 December 2020

Is nephrocalcin related to the urinary derivative (bikunin) of inter-α-trypsin inhibitor?

1 reference

12 December 2020

Protein inhibitors of crystal growth

1 reference

12 December 2020

Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium

1 reference

12 December 2020

Glycosaminoglycans content of stone matrix.

1 reference

12 December 2020

Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation

1 reference

12 December 2020

Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin

1 reference

12 December 2020

Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid

1 reference

12 December 2020

Glycosaminoglycans, proteins, and stone formation: adult themes and child's play

1 reference

12 December 2020

A Method for Discrimination Between Calcium Oxalate Kidney Stone Formers and Normals

1 reference

12 December 2020

The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes

1 reference

12 December 2020

Uropontin in urinary calcium stone formation.

1 reference

12 December 2020

The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin

1 reference

12 December 2020

Isolation of calcium oxalate crystal growth inhibitor from rat kidney and urine

1 reference

12 December 2020

Glycosaminoglycans in urolithiasis

1 reference

12 December 2020

The urinary excretion of citric, hippuric, and lactic acid in normal adults and in patients with calcium oxalate urinary calculus disease

1 reference

12 December 2020

Excretion of inhibitors of calcification in urine. Part I. Findings in control subjects and patients with renal stones

1 reference

12 December 2020

Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers

1 reference

12 December 2020

Mechanism of calcification: inhibitory role of pyrophosphate

1 reference

12 December 2020

Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide

1 reference

12 December 2020

Urinary risk factors in calcium oxalate stone disease: comparison of men and women

1 reference

12 December 2020

The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects

1 reference

12 December 2020

The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro

1 reference

12 December 2020

Inter-α-trypsin inhibitor: emergence of a family within the Kunitz-type protease inhibitor superfamily

1 reference

12 December 2020

Urinary glycosaminoglycans in normal subjects and patients with stones

1 reference

12 December 2020

The amount and nature of the organic matrix in urinary calculi: a review

1 reference

12 December 2020

Effects of human urine on aggregation of calcium oxalate crystals

1 reference

12 December 2020

The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic

1 reference

12 December 2020

Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization

1 reference

12 December 2020

Uromucoids and urinary stone formation

1 reference

12 December 2020

THE RELATION BETWEEN THE URINARY EXCRETION OF CITRIC ACID AND CALCIUM; ITS IMPLICATIONS FOR URINARY CALCIUM STONE FORMATION

1 reference

12 December 2020

Juvenile Renal Stone Disease: A Study of Urinary Promoting and Inhibiting Factors

1 reference

12 December 2020

TOTAL NONDIALYZABLE SOLIDS (TNDS) IN HUMAN URINE. XIII. IMMUNOLOGICAL DETECTION OF A COMPONENT PECULIAR TO RENAL CALCULOUS MATRIX AND TO URINE OF CALCULOUS PATIENTS.

1 reference

12 December 2020

Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor

1 reference

12 December 2020

Crystallization of calcium oxalate from synthetic urine

1 reference

12 December 2020

Modifiers of calcium oxalate crystallization found in urine. II. Studies on their mode of action in an artificial urine

1 reference

12 December 2020

Effects of magnesium deficiency on intratubular calcium oxalate formation and crystalluria in hyperoxaluric rats

1 reference

12 December 2020

Tamm-Horsfall glycoprotein--inhibitor or promoter of calcium oxalate monohydrate crystallization processes?

1 reference

12 December 2020

Pentosan Polysulfate As An Inhibitor of Calcium Oxalate Crystal Growth

1 reference

12 December 2020

The Relationship of the Urinary Cations, Calcium, Magnesium, Sodium and Potassium, in Patients with Renal Calculi

1 reference

12 December 2020

Citrate in daily and fasting urine: results of controls, patients with recurrent idiopathic calcium urolithiasis, and primary hyperparathyroidism

1 reference

12 December 2020

Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro.

1 reference

12 December 2020

Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystallizer using an artificial urine

1 reference

12 December 2020

Organic matrix of human urinary concretions

1 reference

12 December 2020

The Role of Inhibitors and other Factors in the Pathogenesis of Recurrent Calcium-Containing Renal Stones

1 reference

12 December 2020

Crystalluria in Normal Subjects and in Stone Formers With and Without Thiazide and Cellulose Phosphate Treatment

1 reference

12 December 2020

Further evidence linking urolithiasis and blood coagulation: urinary prothrombin fragment 1 is present in stone matrix

1 reference

12 December 2020

Specific isolation and analysis of mucopolysaccharides (glycosaminoglycans) from human urine

1 reference

12 December 2020

Tamm and Horsfall glycoprotein does not promote spontaneous precipitation and crystal growth of calcium oxalate in vitro

1 reference

12 December 2020

The effect of glycosaminoglycans on the crystallisation of calcium oxalate

1 reference

12 December 2020

Risk Factors in Calcium Stone Disease of the Urinary Tract

1 reference

12 December 2020

Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation

1 reference

12 December 2020

An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine

1 reference

12 December 2020

Promoters and inhibitors of calcium urolithiasis in children

1 reference

12 December 2020

Urinary excretion of glycosaminoglycans in urological disease

1 reference

12 December 2020

Urinary citrate excretion in patients with renal calculi

1 reference

12 December 2020

Uromucoid excretion of normal individuals and stone formers

1 reference

12 December 2020

Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine

1 reference

12 December 2020

The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin

1 reference

12 December 2020

Idiopathic calcium nephrolithiasis. 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation

1 reference

12 December 2020

Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects

1 reference

12 December 2020

Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon

1 reference

12 December 2020

[The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone]

1 reference

12 December 2020

Crystal Matrix Protein Is Related to Human Prothrombin

1 reference

12 December 2020

Molecular characteristics of uronic-acid-rich protein, a strong inhibitor of calcium oxalate crystallization in vitro

1 reference

12 December 2020

Citric acid excretion in normal adults and in patients with renal calculus

1 reference

12 December 2020

The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro

1 reference

12 December 2020

Presence or absence of inhibitor of calcium-oxalate crystal growth in urine of normals and of stoneformers

1 reference

12 December 2020

Some Observations on Rachitic Rat Cartilage of Probable Significance in the Etiology of Renal Calculi.

1 reference

12 December 2020

Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers

1 reference

12 December 2020

Isolation from urine of pyrophosphate, a calcification inhibitor

1 reference

12 December 2020

Immunohistochemical distribution and quantification of crystal matrix protein

1 reference

12 December 2020

Structure and expression of the mRNA encoding urinary stone protein (osteopontin).

1 reference

12 December 2020

Growth studies of calcium oxalate in the presence of various ions and compounds

1 reference

12 December 2020

The urinary excretion of inorganic pyrophosphate by normal subjects and patients with renal calculus.

1 reference

12 December 2020

Inhibition of Calcium Oxalate Crystallisation by Pentosan Polysulphate in Control Subjects and Stone Formers

1 reference

12 December 2020

Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth

1 reference

12 December 2020

Low urinary citrate excretion in nephrolithiasis

1 reference

12 December 2020

Urinary glycosaminoglycan excretion in healthy and stone-forming children

1 reference

12 December 2020

Urinary pyrophosphate in normal subjects and in stone formers

1 reference

12 December 2020

[Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro]

1 reference

12 December 2020

Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors

1 reference

12 December 2020

Excessive crystal agglomeration with low citrate excretion in recurrent stone-formers

1 reference

12 December 2020

The evaluation of risk factors in male stone-formers attending a general hospital out-patient clinic

1 reference

12 December 2020

Hypocitraturia in calcium nephrolithiasis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02201852

1 reference

Dimensions Publication ID

2 October 2017

1038119794

0 references

Fatcat ID

release_pzy77gu37zgebelosliadevw3a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pzy77gu37zgebelosliadevw3a

24 November 2022

mapped directly with Wikidata item

1 reference